U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
Show Filters
Hide Filters
Originator
Agouron Pharmaceuticals
11
Pfizer
420
Eli Lilly
237
Merck
216
GlaxoSmithKline
193
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Development Status
Investigational
8
US Approved Rx
3
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Primary Target
PARP 1, 2 and 3
3
Matrix metalloproteinase 13
2
Matrix metalloproteinase 14
2
Matrix metalloproteinase 3
2
Matrix metalloproteinase 9
2
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Highest Phase
Phase III
4
Approved
3
Phase II
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Approval Year
Unknown
8
2016
3
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Condition
Breast cancer
3
Castrate-resistant prostate cancer
3
Melanoma
3
Ovarian cancer
3
Hepatocellular carcinoma
2
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Treatment Modality
Primary
8
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
CNS Activity
CNS Penetrant
2
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Substance Class
Chemical
11
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Code System
CAS
11
FDA UNII
11
PUBCHEM
11
NCI_THESAURUS
10
SMS_ID
9
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
ATC Level 1
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
ATC Level 2
ANTINEOPLASTIC AGENTS
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
ATC Level 3
OTHER ANTINEOPLASTIC AGENTS
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
ATC Level 4
Other antineoplastic agents
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Substance Form
Principal Form
6
Salts, Hydrates, Esters, etc.
5
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Originator
Agouron Pharmaceuticals
Showing
11 - 11
of
11
results
Search within data set
First page
Previous page
1
2
Next page disabled
Next page disabled
Sort By
Approval Year, Recent
Approval Year, Oldest
Relevance
Display Name, A-Z
Display Name, Z-A
Least References
Most References
Oldest Change
Newest Change
METESIND GLUCURONATE
MORE DETAILS
8EC044476N
Export Data
Search for Structure
Status:
Investigational
Class (Stereo):
CHEMICAL (ABSOLUTE)
Metesind (AG-331) is a lipophilic thymidylate synthase inhibitor. It inhibits the cofactor binding site of the enzyme. It exerts cytotoxic properties. Metesind was being developed as an anticancer and antimetabolite agent.
Showing
11 - 11
of
11
results
Search within data set
First page
Previous page
1
2
Next page disabled
Next page disabled
